SLC10A2: Ileal sodium/bile acid cotransporter
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Plays a critical role in the sodium-dependent reabsorption of bile acids from the lumen of the small intestine.
- Drugs that act on it: 5
- With a US drug page: 3
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Linerixibat | Approved | Ileal bile acid transporter inhibitor | Inhibitor | — |
| Maralixibat | Approved | Ileal bile acid transporter inhibitor | Inhibitor | — |
| Odevixibat | Approved | Ileal bile acid transporter inhibitor | Inhibitor | — |
| Elobixibat | — | Ileal bile acid transporter inhibitor | Inhibitor | — |
| Volixibat | — | Ileal bile acid transporter inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associationsDrugs and mechanisms are from ChEMBL CHEMBL2778 (CC BY-SA 3.0). Gene name, function (UniProt Q12908, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets